Literature DB >> 9673273

Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19.

D J Comerci1, G D Pollevick, A M Vigliocco, A C Frasch, R A Ugalde.   

Abstract

A vector for the expression of foreign antigens in the vaccine strain Brucella abortus S19 was developed by using a DNA fragment containing the regulatory sequences and the signal peptide of the Brucella bcsp31 gene. This fragment was cloned in broad-host-range plasmid pBBR4MCS, resulting in plasmid pBEV. As a reporter protein, a repetitive antigen of Trypanosoma cruzi was used. The recombinant fusion protein is stably expressed and secreted into the Brucella periplasmic space, inducing a good antibody response against the T. cruzi antigen. The expression of the repetitive antigen in Brucella neither altered its growth pattern nor generated a toxic or lethal effect during experimental infection. The application of this strategy for the generation of live recombinant vaccines and the tagging of B. abortus S19 vaccine is discussed. This is the first time that a recombinant protein has been expressed in the periplasm of brucellae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673273      PMCID: PMC108437     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  High efficiency transformation of Escherichia coli with plasmids.

Authors:  H Inoue; H Nojima; H Okayama
Journal:  Gene       Date:  1990-11-30       Impact factor: 3.688

2.  The complete sequence of a shed acute-phase antigen of Trypanosoma cruzi.

Authors:  G D Pollevick; J L Affranchino; A C Frasch; D O Sánchez
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

3.  The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the catalytic domain.

Authors:  C A Buscaglia; O Campetella; M S Leguizamón; A C Frasch
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

4.  Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.

Authors:  A J Winter; G E Rowe; J R Duncan; M J Eis; J Widom; B Ganem; B Morein
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Deletion of the BCSP31 gene of Brucella abortus by replacement.

Authors:  S M Halling; P G Detilleux; F M Tatum; B A Judge; J E Mayfield
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Periplasmic location of Brucella abortus Cu/Zn superoxide dismutase.

Authors:  T J Stabel; Z Sha; J E Mayfield
Journal:  Vet Microbiol       Date:  1994-02       Impact factor: 3.293

9.  The cloning, expression, and nucleotide sequence of a gene coding for an immunogenic Brucella abortus protein.

Authors:  J E Mayfield; B J Bricker; H Godfrey; R M Crosby; D J Knight; S M Halling; D Balinsky; L B Tabatabai
Journal:  Gene       Date:  1988       Impact factor: 3.688

10.  Conservation of antigenicity in a 31-kDa Brucella protein.

Authors:  B J Bricker; L B Tabatabai; B L Deyoe; J E Mayfield
Journal:  Vet Microbiol       Date:  1988-12       Impact factor: 3.293

View more
  14 in total

1.  The Brucella abortus cyclic beta-1,2-glucan virulence factor is substituted with O-ester-linked succinyl residues.

Authors:  Mara S Roset; Andrés E Ciocchini; Rodolfo A Ugalde; Nora Iñón de Iannino
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

2.  A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Authors:  Juan Manuel Spera; Juan Esteban Ugalde; Juan Mucci; Diego J Comerci; Rodolfo Augusto Ugalde
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

3.  In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system.

Authors:  María Inés Marchesini; Claudia K Herrmann; Suzana P Salcedo; Jean-Pierre Gorvel; Diego J Comerci
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

4.  Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.

Authors:  G Briones; N Iñón de Iannino; M Roset; A Vigliocco; P S Paulo; R A Ugalde
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication.

Authors:  R Sieira; D J Comerci; D O Sánchez; R A Ugalde
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

7.  Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants.

Authors:  N Iñón de Iannino; G Briones; M Tolmasky; R A Ugalde
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

Review 8.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Brucella abortus synthesizes phosphatidylcholine from choline provided by the host.

Authors:  Diego J Comerci; Silvia Altabe; Diego de Mendoza; Rodolfo A Ugalde
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

10.  Molecular cloning and characterization of cgt, the Brucella abortus cyclic beta-1,2-glucan transporter gene, and its role in virulence.

Authors:  Mara S Roset; Andrés E Ciocchini; Rodolfo A Ugalde; Nora Iñón de Iannino
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.